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Zika virus (ZIKV) infections in humans are considered to be mild or subclinical. However, during the 
recent epidemics in the Pacific Islands and the Americas, the infection was associated with Quillain-
Barré syndrome and congenital infections with fetal brain abnormalities, including microcephaly. 
Thus, more detailed understanding of ZIKV-host cell interactions and regulation of innate immune 
responses by strains of differential evolutionary origin is required. Here, we characterized the infection 
and immune responses triggered by two epidemic Asian/American lineage viruses, including an isolate 
from fetal brains, and a historical, low passage 1947 African lineage virus in human monocyte-derived 
dendritic cells (DCs) and macrophages. The epidemic Asian/American ZIKV replicated well and induced 
relatively good antiviral responses in human DCs whereas the African strain replicated less efficiently 
and induced weaker immune responses. In macrophages both the African and Asian strains showed 
limited replication and relatively weak cytokine gene expression. Interestingly, in macrophages we 
observed host protein degradation, especially IRF3 and STAT2, at early phases of infection with both 
lineage viruses, suggesting an early proteasomal activation in phagocytic cells. Our data indicates that 
ZIKV evolution has led to significant phenotypic differences in the replication characteristics leading to 
differential regulation of host innate immune responses.
Zika virus (ZIKV) belongs to the family of Flaviviridae, which is a large group of viruses including e.g. Dengue, 
West Nile, Japanese encephalitis, Tick-borne encephalitis and many other important human pathogenic viruses. 
In most individuals ZIKV infection is a self-limiting disease with fever, rash, arthritis, conjunctivitis, malaise 
and headache with perhaps 80% of infected individuals suffering from a very mild or a subclinical infection1. 
However, in 2015 there was increasing evidence that ZIKV is linked to congenital infections leading to sponta-
neous abortions and severe neonatal birth defects2,3. Indeed, it was observed that maternal ZIKV infection can 
spread to the fetal brains causing the death of developing neurons, brain calcification and cortical displacement 
leading to reduced brain volume and development of microcephaly4,5. In addition, ZIKV infections have been 
associated with Guillain-Barré syndrome and likely other milder neurological symptoms that may appear in 
early childhood6. Due to the rapid spread of ZIKV infections in the Americas and accumulating data on severe 
birth defects in children whose mothers had suffered a ZIKV infection during pregnancy, WHO declared ZIKV 
infection as a global health alert during the epidemic in 2015–20167.
ZIKV was identified in Rhesus monkeys in Uganda and the virus was isolated in 19478. Later on, it became 
evident that many Aedes (Stegomyia) species mosquitoes are transmitting the virus to primates and humans9. 
Initially, the ZIKV appearance was restricted to certain areas in Africa and later on in Asia, but in recent years 
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the virus has spread widely in the tropical and subtropical areas in the world. The virus follows well the geo-
graphic distribution of Aedes species mosquitoes such as A. africanus, A. albopictus and A. aegyptii, which are 
the vectors for other important flaviviruses as well. During the last ten years, ZIKV spread to Southeast Asia and 
the Polynesian Islands followed by an extremely rapid spread of the virus in Southern and Central America in 
2015–2016, including the southern parts of the United States1,10–12. During its global spread, the virus has under-
gone marked genetic evolution and presently ZIKV strains have been classified as East African, West African and 
Asian lineages, the latter of which includes the virus strains isolated in the Americas13. At present, there is little 
information whether the viruses from different lineages show significant differences in pathogenesis or in their 
ability to replicate in human cells.
Innate immunity plays an important role in the early phases of microbial infections including viral infections. 
The key cell types regulating innate immunity include dendritic cells (DCs) and macrophages. These cells reside in 
tissues where they are on alert for invading pathogens. DCs take up microbes, microbial components or they are 
infected by viruses, which leads to the activation of the cells, increased cytokine production and migration of acti-
vated DCs into the local lymph nodes where they present microbial antigens to T cells14. DCs thus operate as an 
important cell type regulating both innate and adaptive immunity. Macrophages, instead, reside in tissues where 
they act mainly locally by taking up and destroying microbes as well as by secreting inflammatory cytokines and 
other inflammatory mediators15. Although immature DCs in humans have been shown to be permissive to ZIKV 
infection, there is still some controversy on the impact of lineage differences on the cell-type specific infectivity 
and regulation of innate immunity16–18. Macrophages, which are readily infected by many flaviviruses like Dengue 
and West Nile viruses19,20, have been mostly neglected as a potential target for ZIKV infection.
In the present study, we have characterized Zika virus infection in primary human monocyte-derived DCs 
and macrophages. Firstly, we evaluated the susceptibility of human immune cells to a ZIKV infection. Secondly, 
we compared the infection pattern of Asian lineage fetal brain and blood ZIKV isolates and a historical African 
strain (initially a monkey isolate) in both cell types. We observed that the recent Asian/American lineage Zika 
viruses replicated well in DCs but poorly in macrophages, while the African lineage virus showed limited infec-
tivity in both cell types. The ability of the virus to replicate correlated well with the magnitude of innate antiviral 
gene expression and cytokine production. However, all ZIKV strains analyzed induced innate immune responses 
in such a level that an antiviral state, as evidenced by enhanced expression of antiviral MxA protein, was estab-
lished in both studied human cell types.
Results
Infection of human DCs and macrophages by Zika viruses of different evolutionary lineages. 
In this study we analysed the infection profiles of ZIKV strains of African and Asian lineages in human innate 
immune cell models. A recent Asian lineage ZIKV strain (infection contracted in Guatemala) isolated from fetal 
brains (ZIKV-FB-GWUH-20165), another Asian strain isolated from a viremic adult patient who contracted 
the infection in French Polynesia (ZIKV-H-PF-2013) and an ancestor, low-passage African strain (ZIKV-#976-
Uganda-1947) were used. As shown in Fig. 1A, GWUH is an Asian lineage virus and genetically very closely 
related to the 2015 epidemic Guatemala strains5. The HPF strain is very closely related to the 2015–2016 epidemic 
strains of the Americas of which an isolate from Puerto Rico in 2015 (PRVABC59) is widely used as a reference 
strain for the epidemic13. The genetic difference between the recent epidemic strains and the original African 
lineage viruses is ca. 6% (Fig. 1A).
In order to define the susceptibility of human immune cells to ZIKV infection, we infected primary human 
monocyte-derived DCs and macrophages with the GWUH strain at MOI of 5 (TCID50/cell) and evaluated the 
frequency of virus-infected cells at 48 h post infection (p.i.). In this time point we saw hardly any virus-positive 
DCs by flow cytometric analysis or macrophage infection by immunofluorescent microscopy when an in-house 
produced anti-ZIKV NS3 specific antibody was used. The specificity and sensitivity of anti-ZIKV NS3-specific 
antibodies was excellent in GWUH-infected Vero E6 cells and no background staining was seen in immunoflu-
orescence analysis (Supplementary Fig. S1). To further evaluate ZIKV infection in DCs and macrophages we 
infected the cells with high doses of Asian lineage GWUH and African lineage #976 strains and analysed the 
percentage of virus-infected cells by immunofluorescence staining at 48 h p.i. In DCs very high doses of GWUH 
ZIKV(MOI 25-225) lead to a clearly detectable infection in 2–18% of the cells in different donors (Fig. 1B,C). 
However, in African lineage ZIKV #976 virus-infected DCs, only a few percentage of cells showed evidence of 
virus protein expression (Fig. 1B,C). In macrophages the infectivity rate remained low with both virus strains 
(Fig. 1B). The data indicates that DCs are more permissive to the Asian ZIKV strains, whereas macrophages show 
low susceptibility to both Asian and African ZIKV strains.
Replication of ZIKV in human DCs and macrophages. As human DCs and macrophages were found 
to be rather weakly permissive to ZIKV infection even with an extremely high doses of viruses, we systematically 
evaluated the replication efficiency of the Asian lineage fetal brain isolate GWUH strain and the low passage 
African lineage strain #976 in these cell types. At high MOI values of 75 TCID50/cell, viral RNA and protein 
expression readily increased with peak values seen at 24–48 h p.i. in DCs and at 48–72 h p.i. in macrophages 
(Fig. 2A,B). The Asian lineage GWUH Zika virus replicated better in DCs compared to that in macrophages, 
and strong viral protein expression was seen in infected DCs. Western blot analysis showed that the #976 virus 
replicated to some extent both in DCs and macrophages (Fig. 2B). Altogether, by comparing the ZIKV strains 
from African and Asian lineages, the data indicates that different ZIKV strains show clear differences in their 
replication and viral RNA and protein expression patterns in primary human leukocytes.
In order to evaluate the capability of ZIKV strains to replicate and produce new progeny viruses, we chal-
lenged the cells with low doses of ZIKV GWUH and #976 viruses (MOI 0.2, 1 or 5 TCID50/cell). To analyze the 
productivity of the infection, cell culture supernatants were collected at different time points after infection and 
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Figure 1. Susceptibility of human monocyte-derived dendritic cells (DCs) and macrophages to fetal brain-
isolated Asian lineage ZIKV and historical African lineage ZIKV infection. (A)  Phylogenetic analysis of 
complete coding regions of the Asian and African ZIKV strains used in this study. Maximum Likelihood tree 
based on Tamura-Nei model with bootstrap support of 1000 replicates constructed using MEGA7 is drawn to 
scale with branch lengths measured in the number of substitutions per site. The percentage of replicate trees 
clustered together is shown next to the branches. Viral strains are shown with their name and place of origin. 
(B) Flow cytometric and fluorescence microscopic analysis of ZIKV-infected DCs or macrophages. Cells were 
infected with Asian lineage GWUH or African lineage #976 strains at high MOI values of 25, 75 or 225 TCID50/
cell and the cells were fixed at 48 h after infection. Data is presented as mean +/− SEM of cells generated from 4 
independent blood donors. Individual donors are shown with different symbols. Immunofluorescence images 
of representative mock and GWUH-infected cells at a MOI of 225 TCID50/cell. Blue: DAPI, green:anti-ZIKV 
NS3 antibody staining. (C) Representative histogram patterns from flow cytometric analysis of GWUH or #976 
virus-infected DCs from one donor.
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Figure 2. Comparison of virus replication in human DCs and macrophages infected with Asian and African 
lineage ZIKV strains. The Asian lineage GWUH strain or the African lineage #976 ZIKV strain was used to 
separately infect human DCs or macrophages from four different donors. (A,B) Cells were infected by the 
viruses at MOI of 75 TCID50/cell and collected at different times after infection as indicated in the figure. (A) 
ZIKV RNA expression was quantitated by qRT-PCR using NS5 gene-specific probes. Data is presented as 
mean +/− SEM from four individual donors and a representative experiment out of two is shown. (B) ZIKV-
infected cells from the same 4 donors were collected at different times after infection, cells were pooled and 
proteins were separated on SDS-PAGE, immunoblotted and stained with anti-NS5 and anti-β-Actin antibodies. 
ZIKV-infected Vero E6 cell extract was used as a positive control in immunoblotting. (C) For the measurement 
of infectious ZIKV production into cell supernatants, cells were infected with low doses (MOI values 0.2, 1 or 5 
TCID50/cell) of GWUH or #976 strains followed by collection of cell culture supernatants at times indicated in 
the figure. Viral titers were measured from the supernatant samples using the end-point dilution assay in Vero 
E6 cells (TCID50/ml) and the virus titers were calculated using the Spearman-Karber method. Results represent 
the means +/− SEM from DC or macrophage cultures from four different blood donors.
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viral titers were determined in Vero E6 cells with an end-point dilution assay. Already at 24 h after the infection, 
GWUH virus-infected DCs were found to produce high levels of infectious viruses and the viral titers ranged 
from 104 to almost 107/ml depending on the input MOI values (Fig. 2C). In #976 virus-infected DCs the virus 
production was slower and the amount of secreted viruses continued to increase up to 96 h after infection reach-
ing TCID50 values of 103 to 105/ml (Fig. 2C). In macrophages, instead, the productivity of ZIKV infection was less 
efficient and secreted virus titers remained at low, similar to inoculum virus levels ranging from 102 to 104 TCID50 
values/ml (Fig. 2C). Even though there were differences in the replication of ZIKV in cells obtained from different 
blood donors, ZIKV was able to replicate both in DCs and macrophages. However, clearly detectable increases in 
ZIKV production was only seen in DCs (Fig. 2).
Activation of innate cytokine responses in ZIKV-infected human DCs and macrophages. Since 
the Asian lineage ZIKV GWUH appeared to grow well in DCs but inefficiently in macrophages, and the African 
lineage ZIKV #976 showed weak replication in both cell types, we addressed the question whether these viruses 
would also show differences in innate immune responses they induced. With a high MOI infection of 75 TCID50/
ml both viruses induced IFN-λ1, IFN-β and CXCL10 mRNA expression relatively well in DCs with GWUH strain 
showing ca. 10-fold higher cytokine mRNA levels than the African #976 strain (Fig. 3). In macrophages, instead, 
the infection with the African ZIKV #976 strain led to somewhat higher IFN-λ1, IFN-β and CXCL10 mRNA 
expression levels as compared to those induced by the GWUH strain. It is of interest that the fold induction of 
cytokine mRNAs by the #976 strain was at similar levels in DCs and macrophages, while there was a dramatic 
difference in GWUH virus induced responses between DCs and macrophages in favor of DCs (Fig. 3). Altogether, 
cytokine gene expression levels seemed to follow viral RNA expression patterns (compare Figs 2 and 3). 
Interestingly, type I and type III IFN-inducible MxA gene expression did not show very dramatic differencies 
between the viruses and cell types, which is likely explained by the fact that in primary human leukocytes MxA 
gene is induced with very low doses of IFNs21,22.
We also determined the amounts of secreted IFN-λ1 and IFN-α from virus-infected cells by cytokine-specific 
EIAs. GWUH induced clearly higher levels of secreted type I and type III IFNs in DCs as compared to those seen 
by the #976 virus (Fig. 4). ZIKV-infected macrophages produced extremely low levels of IFNs into cell culture 
supernatants and they were found only in late time points of infection (data not shown). Altogether, the secreted 
levels of IFNs were in good agreement with Zika virus replication and virus-induced cytokine mRNA levels in 
different types of cells (Figs 2–4).
Activation of IRF3 and STAT2 signaling molecules in ZIKV-infected human DCs and mac-
rophages. Since both the Asian and African lineage Zika viruses induced cytokine gene expression in human 
DCs and also weakly in macrophages, we analyzed the level of phosphorylation of IRF3 and STAT2 in response 
to ZIKV infection. In addition, the expression of IRF3, STAT2 and antiviral MxA proteins were also analysed. In 
Asian lineage GWUH virus-infected DCs, we could only detect a very weak signal corresponding to the phos-
phorylated form of IRF3 (P-IRF3), while in influenza A virus-infected cells (a positive control) P-IRF3 was readily 
detectable (Fig. 5A). Starting at 24 h after infection, we observed the appearance of phospho-STAT2 (P-STAT2) 
and an enhanced expression of STAT2, MxA and ZIKV NS5 proteins. In DCs the African #976 ZIKV strain was 
also able to induce the phosphorylation of STAT2 (P-STAT2) but no P-IRF3 was detectable. The expression of 
STAT2, MxA and ZIKV NS5 protein was enhanced starting at 24 h after infection with the #976 virus. As a whole, 
the observation is indicative of efficient type I and type III IFN secretion (IFN-α/β and IFN-λs, respectively), 
which are known to activate and phosphorylate STAT2 and enhance the expression of STAT2 and MxA, which 
are well-known IFN-inducible genes21,23.
In macrophages, we could not find any detectable P-IRF3 in GWUH or #976 ZIKV-infected cells. Interestingly, 
in macrophages, the expression of total IRF3 or STAT2 protein levels seemed to be reduced at 2 and 6 h after 
infection with both types of viruses (Fig. 5B). However, at later times of infection (24–48 h) the expression of 
IRF3 returned back to basal levels and the expression of STAT2 was clearly enhanced. An early IRF3 and STAT2 
degradation was induced by both the African #976 and the Asian GWUH strains irrespective of their differential 
growth or cytokine responsiveness in macrophages (Figs 1–4). In addition, STAT2 was phosphorylated and the 
expression of both STAT2 and MxA proteins was seen starting at 24 h after the infection with either one of the 
viruses indicating that at least some IFN production took place in macrophages in response to ZIKV infection 
(Fig. 5B). It was of interest that some P-STAT2 was detectable in macrophages at 2–6 h after infection with the 
#976 virus (Fig. 5B right panel). This could be due to residual amounts of IFNs in Vero E6 cell-produced ZIKV 
stocks, albeit Vero cells are considered to be IFN-deficient24. Indeed, some IFN-λ1 (<100 pg/ml) was detectable 
by IFN-specific EIA in ZIKV stocks. In most experiments the stocks were diluted to levels where STAT2 phos-
phorylation did not take place (Fig. 5).
Characterization of ZIKV infection and activation of innate immunity induced by Asian ZIKV 
strains of different origin. Next we compared the ability of two recent Asian lineage ZIKV isolates, the fetal 
brain isolate GWUH and HPF, a virus isolated from the serum specimen of an adult patient (ZIKV-H-PF-2013), 
to replicate and induce cytokine responses in human DCs and macrophages. Cells were infected at MOI of 2 for 
different time periods followed by isolation of total cellular RNA and qRT-PCR analysis to quantitate ZIKV RNA 
expression. Due to a considerable variability between the cells of different blood donors (Fig. 1B)17, virus-infected 
cells of different donors were pooled for RNA analysis in order to get a more global and general view of the 
infection kinetics. In DCs, both Asian Zika virus strains appeared to replicate with a similar efficacy (Fig. 6A). In 
ZIKV-infected macrophages, the expression of viral RNA was increased to some extent, but the levels remained 
much lower (one log) compared to viral RNA levels seen in DCs (Fig. 6A). The data clearly shows that, albeit both 
ZIKV strains are able to infect both human DCs and macrophages, virus replication is better in DCs.
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Since the two analysed Asian lineage ZIKV strains appeared to replicate equally well in DCs and macrophages 
we analysed whether they also induced cytokine gene expression equally well. In DCs, both viruses were able 
to induce mRNA expression of IFN-λ1, IFN-β, CXCL10 and IFN-inducible MxA genes apparently at similar 
rates (Fig. 6B). Induced cytokine mRNAs were seen already 6 h after infection and the induced levels peaked at 
24–48 h p.i. Quantitative RT-PCR analyses revealed induced cytokine and MxA mRNA levels to range from 100 
to 1000-fold over the basal levels. However, in DCs ZIKV-induced cytokine mRNA levels remained approxi-
mately 10 to 100-fold lower levels compared with those induced by influenza A virus (Fig. 6B). It has to be pointed 
out that in general, influenza A virus is an excellent inducer of cytokine gene expression in human primary DCs 
Figure 3. Differential induction of cytokine mRNA expression in human DCs and macrophages infected with 
Asian and African lineage ZIKV strains. Human monocyte-derived DCs or macrophages obtained from four 
different blood donors were separately infected with a fetal brain-isolated GWUH strain (Asian lineage) or with 
an African lineage #976 ZIKV strain at MOI of 75 TCID50/cell. The cells were collected at different times after 
infection and total cellular RNA was isolated. The expression of IFN-λ1, IFN-β, CXCL10 and MxA mRNA was 
analyzed by qRT-PCR. The mRNA levels are presented as fold induction compared to the mock sample. The 
data (means +/− SEM) shown is a representative experiment out of two independent experiments.
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and macrophages21,25. In macrophages, the expression of cytokine genes remained close to the undetectable levels 
with both Asian lineage viruses (data not shown).
ZIKV is highly sensitive to the antiviral actions of type I IFNs. Next, we addressed the question 
whether the recent Asian lineage Zika viruses are sensitive to the antiviral effects of type I IFNs (IFN-β). Human 
DCs or macrophages were pretreated with recombinant human IFN-β with 10 or 100 IU/ml followed by infection 
with GWUH ZIKV (MOI 2). At 24, 48 and 72 h after the infection cells were collected, total cellular RNA was 
isolated and ZIKV RNA expression was analyzed by qRT-PCR. Pretreatment with as low as 10 IU/ml of IFN-β 
led to almost complete inhibition of ZIKV replication in DCs (Fig. 7A). In macrophages, ZIKV replication was 
also dramatically reduced by IFN-β pretreatment even though some residual viral RNA expression remained 
(Fig. 7B). This suggests that, in accordance with previous studies done in human DCs, human skin fibroblasts and 
human lung epithelial cell line A54917,18,26, in our primary immune cell models the epidemic ZIKV was highly 
sensitive to the antiviral actions of type I IFNs.
Since it was apparent that type I IFNs played an important role in inhibiting the replication of ZIKV, we 
conducted in vitro infection experiments in wild-type or type I IFN receptor chain 1 (IFNAR1) knock-out 
mouse embryonal fibroblasts (MEFs). MEFs were productively infected by the Asian lineage GWUH or HPF 
Zika viruses and the expression of ZIKV RNA, as analyzed by qRT-PCR, was very high in IFNAR1 KO cells as 
compared to the wild-type MEFs (Fig. 7C). Viral RNA levels were approximately 50–100-fold higher in IFNAR1 
KO cells compared to those seen in wild-type cells, indicating an important role of type I IFNs in restricting the 
infection in cell culture.
Discussion
The ZIKV epidemic in the Americas and its association with congenital defects like microcephaly raised a global 
infection alert. The characterization of ZIKV infection and the immune regulation induced by the infection have 
been studied in different in vitro cell lines as well as in type I IFN receptor knockout mouse model27. However, 
the studies in primary human immune cell models have remained rare. In the present study, we have demon-
strated that virus strains from different ZIKV lineages show differential replication capacity and ability to induce 
innate immune responses in human monocyte-derived DCs and macrophages. We observed a productive infec-
tion in DCs with a recent epidemic ZIKV strain, while virus replication remained at a very low level in human 
macrophages as noted by low viral RNA and protein expression. Despite that, a clear antiviral state was likely 
established in response to virus infection as we observed marked MxA expression in macrophages infected with 
the Asian Zika virus strain. However, both cell types were as permissive to the African lineage virus and virus 
replication led to the activation of innate immune responses. Thus, we observed clear differences in virus strains 
of differential evolutionary origin in their ability to replicate and induce innate immune responses in primary 
human immune cells.
The reports of human infections with ZIKV remained sporadic until the outbreak in Yap Island in 2007 which 
proceeded with a rapid virus spread through the Pacific Islands to Southern and Central Americas in 2013–
20151,13. The absence of monkeys in the French Polynesian islands suggests that humans must have served as 
the amplification host for ZIKV during that epidemic28. The possibility that birds could transfer the virus along 
their migration routes for long distances is still unclear29. Also, the neurotropic clinical picture of ZIKV infection 
suggests that the increased pathogenicity may, at least partly, be due to evolutionary changes in the virus. In the 
present study, our goal was to compare the infection of a historical, low passage African strain and two recent 
epidemic strains, the other one of which was isolated from fetal brains. Previously, it has been shown that the 
fetal brain isolate GWUH has a replicative advantage over other related epidemic strains or the prototype African 
strain MR766 in some cell lines, such as in glioma cells or in microvascular endothelial cells of the newborn30. 
The GWUH strain has 10 amino acid differences from the HPF strain30, the other Asian strain used in the present 
Figure 4. Production of IFNs from ZIKV-infected DCs. For the measurement of secreted IFN-λ1 and IFN-α 
protein levels with enzyme immunoassay (EIA), cell culture supernatants were collected at different times after 
infection with GWUH or #976 strains at MOI of 75 TCID50/cell. The samples were analysed in duplicates in EIA 
assay. The supernatants from ZIKV-infected DCs (obtained from 4 donors) were analysed separately and the 
results are presented as the mean values +/− SEM and the data of individual donors are shown with different 
symbols.
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study. However, these changes apparently did not affect the growth properties of the viruses in immune cells since 
both viruses showed similar growth kinetics and comparable innate immune responses (Fig. 6). This suggests 
that although the GWUH virus strain was isolated from the brains and it was likely adapted to fetal neuronal 
cells, it still maintains the ability to replicate in adult peripheral blood cells. The prototype African strain MR766 
has been passaged several times in various laboratory models (suckling mouse brains and cell lines) and thus the 
virus shows adaptation to cell culture environment31. Therefore, we used another ancestral African lineage isolate, 
#976 which was available as a low passage mouse brain isolate (3 passages) followed by cultivation in Vero E6 cells 
(4 passages). This virus, which was initially a monkey isolate, showed replication in both DCs and macrophages 
Figure 5. Expression of signaling molecules and antiviral proteins in ZIKV-infected human DCs and 
macrophages. Human primary (A) DCs and (B) macrophages were infected with GWUH or #976 ZIKV strains 
at a MOI of 75 TCID50/cell and the cells from four individual blood donors were collected at different time 
points after infection, pooled and cellular protein samples were prepared for immunoblotting. Uninfected mock 
samples were used as negative control and influenza A virus-infected cells (MOI 1, 24 h infection) as positive 
control samples. The expression levels of phospho-IRF3 (P-IRF3), IRF3, phospho-STAT2 (P-STAT2), STAT2 
and antiviral MxA proteins were analyzed by immunoblotting using specific antibodies. The expression of ZIKV 
NS5 protein was analyzed for visualizing the virus replication with ZIKV-infected DCs and macrophages. ZIKV 
infected (GWUH) Vero E6 cell lysate functioned as a positive control, and GAPDH and β-Actin were stained as 
loading controls. The data shown is a representative experiment out of two independent experiments (altogether 
n = 8).
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in contrast to the recent epidemic Asian strains which showed attenuated replication in human macrophages 
(Figs 1–2). In line with this, the only available studies on human blood-derived macrophages show that this cell 
model is permissive to a recent ZIKV strain (PRVABC59)32,33. Moreover, Khaibouillina and co-workers com-
pared the infectivity of African and Asian strains and found, in accordance with us, a higher susceptibility of 
macrophages to the African ZIKV strain32. In DCs, Bowen and co-workers observed a faster infection kinetics 
with the African strain compared to that of the Asian lineage virus17. However, Vielle and co-workers did not find 
lineage-specific differences in infection profiles16. In our study, GWUH and #976 both induced IFN gene expres-
sion and cytokine secretion correlated with the magnitude of virus replication, but antiviral MxA expression was 
observed at similar levels (Figs 3–5). Similar findings were reported by Bowen and co-workers although they 
showed reduced IFN secretion suggesting that ZIKV could block the translation of IFN mRNAs but yet induce 
an antiviral state17. This observation can, however, be explained by a possibility that small amounts of secreted 
type I and type III IFNs were rapidly used up by the cells to induce an antiviral response. Our data rather points to 
that direction since ZIKV induced IFN gene expression at a much lower level as compared to our positive control 
virus, influenza A virus, but yet the expression of antiviral MxA protein was readily induced by both viruses. It 
is of note that in the study of Bowen and co-workers a cell culture-adapted MR766 strain was used and thus the 
Figure 6. Expression of ZIKV RNA and host innate immune genes in human DCs and macrophages infected 
with two recent Asian lineage ZIKV strains. Differentiated DCs and macrophages from four independent 
blood donors were separately infected with GWUH or HPF strains at MOI of 2 and analyzed for the expression 
of viral RNA (panel A) or host cell antiviral genes (panel B) at different times after infection during a 4-day 
infection experiment. (A) For viral RNA expression cells were collected at different times after infection, cells 
from different donors were pooled and total cellular RNA was extracted and qRT-PCR analysis for ZIKV RNA 
(using NS5 gene as a target) was carried out. (B) The DCs from different donors were collected, pooled and total 
cellular RNA was isolated followed by quantitation of IFN-λ1, IFN-β, CXCL10 and MxA mRNA expression by 
qRT-PCR. As a positive control cells were infected with influenza A/Beijing/353/89 virus at MOI of 1 for 24 h. 
The results are shown as fold induction over the mock sample and the data is representative of two individual 
experiments (altogether n = 8).
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comparison to low passage epidemic strains may be difficult. Collectively, the published and our data indicate that 
ZIKV is able to induce IFN and IFN-induced antiviral gene expression in human immune cells, but the recent 
Asian-American lineage ZIKV strains have evolved to show restricted replication in human macrophages.
Given that the maternal ZIKV infection can be transmitted vertically to the developing fetus4,5, several stud-
ies have thus focused on identifying the target cells of ZIKV infection in the placenta and the uterus. Several 
placental cell types have been shown to be permissive to ZIKV infection, including placental fibroblast, human 
umbilical vein endothelial cells (HUVEC), placental trophoblasts and placental macrophages (Höfbauer cells)34. 
Interestingly, human placental macrophages showed a more productive infection with recent epidemic ZIKV 
strains compared with the placental trophoblasts35, which have been postulated to transmit resistance to ZIKV 
infection both in an autocrine and paracrine manner by secreting antiviral IFN-λ136. There is evidence for an 
important role of IFN-λs in epithelial/endothelial-immune cell barrier against several human viral pathogens, 
including Dengue virus37, influenza A virus38, as well as other viruses infecting the respiratory39 or gastroin-
testinal tract40. In accordance with previous studies on macrophages32,33, we also found out that human blood 
monocyte-derived macrophages can be infected with recent ZIKV isolates, even though the level of virus rep-
lication and host IFN gene expression remains at a very low level. Quicke and colleagues showed that placental 
macrophages were highly permissive to the epidemic ZIKV strains which induced the production of IFNs35. In 
addition, the study by Foo and co-workers shows that during pregnancy, the primary target cells for ZIKV infec-
tion in in vitro whole blood cell infection are CD14+ monocytes41. Furthermore, the same authors demonstrated 
that an Asian lineage ZIKV infection promoted the differentiation of non-classical M2-type, IL-10-expressing 
immunosuppressive monocytes by inhibiting the IFN pathway. However, the infection with an African ZIKV 
strain led to monocyte differentiation to M1-type inflammatory responses with increased IFN-induced CXCL10 
production41. This is well in line with our macrophage results, where the early African lineage virus was able to 
induce innate immune responses (IFN-λ1, IFN-β and CXCL10 expression) but innate immunity was more weakly 
induced by the Asian ZIKV strain (Fig. 3). These findings may provide insights into immunological differences 
Figure 7. ZIKV is highly sensitive to the antiviral activity of type I IFNs. Monocyte-derived human (A) DCs or 
(B) macrophages from 4 individual blood donors were primed with different doses of IFN-β (0, 10 or 100 IU/
ml) for 16 h followed by infection with the ZIKV GWUH strain (MOI 2). Cells were collected at different time 
points after infection and samples from different donors were pooled for isolation of total cellular RNA. Virus 
replication was analyzed by quantitating viral RNA by qRT-PCR. The results are presented as relative expression 
over the mock sample without cytokine stimulation or virus infection. (C) Mouse embryonal fibroblasts (MEFs) 
from wild-type mouse (IFNAR1 wt) and from IFN-α receptor chain 1 knock-out (Ifnar-1−/−; IFNAR1 KO) 
mouse were infected with GWUH or HPF strains of ZIKV at MOI of 2 and cells were harvested at different time 
points after infection followed by isolation of total cellular RNA. Viral RNA expression was quantitated by qRT-
PCR, and results are shown as relative expression over the uninfected sample.
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between early African and recent Asian-American ZIKV strains which may be associated with increased fre-
quency of congenital infections.
There is evidence that the primary target cells of ZIKV infection, skin fibroblasts and DCs are highly per-
missive to ZIKV, but yet the infection induces only weak immune responses16–18. This suggests that ZIKV must 
have efficient ways to antagonize virus-induced IFN signaling. Recent studies from many groups have postu-
lated different molecular mechanisms by which ZIKV evades host’s IFN-mediated antiviral protection during 
the infection. The most convincing evidence is that ZIKV NS5 is interfering with IFN signaling by inducing 
the degradation of STAT2 protein. Studies by Kumar and co-workers with an Asian lineage virus HPF, Grant 
and co-workers with an African lineage virus MR766 and Hertzog and colleagues with an Asian lineage fetal 
brain-isolate, have shown that NS5 mediates the proteasomal degradation of STAT2 in human cell lines42–44. In 
productive ZIKV infection, STAT2 degradation has been shown to occur in Vero cells43 and in human lung epi-
thelial A549 and fetal astrocyte HFA cells42. In contrast to these observations, Bowen and colleagues reported a 
lack of STAT2 degradation in live infection in human A549 cells or in human DCs. In fact, the authors observed 
an increase in STAT2 levels together with other IFN-stimulated genes during ZIKV infection17. However, they 
reported a significant inhibition of STAT1 and STAT2 phosphorylation, which was also similarly observed in the 
case of STAT1 in the study by Hertzog and colleagues17,44. In our study, we saw a clear increase in STAT2 levels 
together with IFN-induced MxA expression in DCs, which was likely due to ZIKV induced type I and type III 
IFNs at late time points of infection. The phosphorylated form of STAT2 appeared at 24 h and peaked at 48 h 
p.i. and then gradually reduced during a 96 h follow-up (Fig. 5A). Before the reduction in STAT2 activation, 
the expression of viral proteins was observed (Fig. 5A), suggesting that in primary human DCs ZIKV infection 
is leading to down-regulation of STAT signaling. The role of STAT2 in the pathogenesis of ZIKV has now been 
proven also with STAT2 knock-out mouse and hamster models45,46.
Surprisingly, we observed IRF3 and STAT2 degradation in macrophages at early times of ZIKV infection. This 
degradation was evident for both African and Asian strains. Macrophages are professional phagocytic cells, and 
viral recognition leads to an antiviral response including the activation of phagocytosis of the virus and phago-
lysosome activation. ZIKV NS5 has been associated with proteasomal degradation of STAT2, but this takes place 
only after viral NS5 protein is expressed42–44. It was of interest that the degradation of IRF3 and STAT2 in mac-
rophages took place at early hours of ZIKV infection, clearly before viral protein expression occurred (Fig. 5B). 
This suggests, that during the ZIKV entry process, the virus is likely activating the host proteasome/lysosome 
pathways. This finding could provide insights into a completely new evasion strategy of ZIKV where the early 
events of ZIKV entry trigger the degradation of innate signaling molecules. Other flaviviruses have been shown 
to utilize various immune evasion strategies in addition of inhibiting the signal transduction by non-structural 
proteins. For instance, Dengue and Tick-borne encephalitis viruses have been shown to use specific membrane 
vesicle structures to hide viral replication products in order to evade the host recognition47,48. Further studies are 
warranted to investigate the mechanisms of degradation of host signaling molecules during the early phases of 
ZIKV infection in human macrophages.
An early degradation of IRF3 and other molecules regulating pathogen recognition could lead to impaired IFN 
responses during ZIKV infection. In addition of blocking IFN signaling via NS5-mediated degradation of STAT2, 
several studies have reported an inhibition of RLR signaling suggesting another evasion strategy for ZIKV. With 
promoter-reporter assays some ZIKV proteins, especially that of NS5 have been associated with an inhibition of 
IFN gene expression42,44. NS1 and NS4B have also been reported to inhibit RLR-mediated IFN gene expression 
by inhibiting the phosphorylation of TBK1 and IRF349. Thus, the exact molecular mechanisms by which ZIKV is 
interfering with IFN induction and IFN signaling still needs further analysis in order to understand the patho-
genicity of ZIKV and identifying the targets for therapeutic interventions in severe ZIKV infections.
In summary, we show here that recent epidemic Zika virus strains replicate very well in human DCs with 
strong IFN induction, but their replication is attenuated in macrophages likely leading to impaired host innate 
immune responses. The infection rate of a historical African ZIKV strain, instead, remains low in both human 
DCs and macrophages, and the virus activates relatively weak IFN-induced antiviral responses in these cells. In 
conclusion, our findings indicates that ZIKV evolution has led to cell-type specific differences in the infectivity 
leading to differential regulation of host innate immune responses in humans.
Materials and Methods
Ethics statement. This study was carried out with cultured leukocytes using primary human cells from 
anonymous buffy coat samples obtained from voluntary adult blood donors from the Finnish Red Cross Blood 
Service (Blood Service Center Helsinki, Finland). The use of buffy coats for research purposes was approved 
by the Finnish Red Cross Blood Service Institutional review board (licence number 37/2016, renewed once 
a year) by which the need for informed consent was waived. Ethical approval for animal immunization was 
provided by the Ethics committee of animal experimentation in Southern Finland (permission no: ESLH-
ESAVI/11411/04.10.07/2014 to DVM Anna Meller). All experimental protocols were approved and performed in 
accordance with the guidelines of the Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Cell cultures. Monocyte-derived dendritic cells (DCs) and macrophages were differentiated from periph-
eral blood monocytes isolated from the buffy coat fractions collected from healthy blood donors (Finnish Red 
Cross Blood Service, Helsinki, Finland) according to a standard procedure50,51. In brief, peripheral blood mon-
onuclear cells (PBMC) were fractionated by Ficoll-Paque (Pharmacia Biotech) gradient centrifugation. For 
macrophage cultures, monocytes from the PBMC fraction were allowed to adhere onto cell culture plates and 
macrophages were differentiated by culturing the cells for 7 days in macrophage serum-free substitution medium 
(Gibco Invitrogen) supplemented with 0.6 µg/ml penicillin and 60 µg/ml streptomycin in the presence of 10 ng/ml 
human granulocyte-macrophage colony-stimulating factor (GM-CSF) (Gibco Invitrogen). For DCs, PBMC 
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fraction was subjected to an additional centrifugation on a Percoll gradient (Amersham Biosciences) and lym-
phocyte depletion with anti-CD3 and anti-CD19 magnetic beads (Dynal). DCs were differentiated by culturing 
monocytes in RPMI medium (Sigma Aldrich) supplemented with 0.6 µg/ml penicillin, 60 µg/ml streptomycin, 
2 mM L-glutamine and 20 mM HEPES in the presence of 10% fetal calf serum (FCS) (Sigma Aldrich), 10 ng/ml 
GM-CSF (Gibco Invitrogen) and 20 ng/ml IL-4 (GenScript) for 1 week. In all experiments cells from 4 different 
blood donors were used separately for virus infection and all experiments were repeated several times as indicated 
in figure legends.
Vero E6 green monkey kidney (ATCC CRL-1586) cells were maintained in Eagle’s minimum essential 
medium (E-MEM) supplemented with 0.6 µg/ml penicillin, 60 µg/ml streptomycin, 2 mM L-glutamine, 20 mM 
HEPES and 10% FCS (Sigma Aldrich). Spodoptera frugiperda (Sf9) cells were used for baculovirus expression and 
maintained in TNM-FH medium or in EX-C420 Serum-Free Medium (Sigma Aldrich) supplemented with 10% 
FCS (Sigma-Aldrich) as described previously52. Mouse embryonic fibroblast (MEFs) from wild-type mouse and 
from Ifnar-1−/− mouse, both expressing Mx1, were kindly provided by Prof. P. Staeheli, Freiburg, Germany. The 
primary MEFs were immortalized by using a rigorous passaging protocol to obtain wt and KO cell lines. The MEF 
cell lines were cultured in Dulbecco’s modified Eagle’s Medium (D-MEM) supplemented with 0.6 µg/ml penicil-
lin, 60 µg/ml streptomycin, 2mM L-glutamine, 20 mM HEPES and 10% FCS.
Viruses and infections. Zika virus strain ZIKV-FB-GWUH-2016 (GenBank number KU870645) was iso-
lated from a fetal brain tissue by Vapalahti and colleagues5, and it is a member of an Asian ZIKV genotype. 
Another recent Asian lineage Zika virus strain ZIKV-H-PF-2013 (GenBank number KJ776791.2), originally a 
clinical isolate from a viremic adult patient from French Polynesia in 2013, was obtained from European Virus 
Archive (EVA, Marseille, France). The low-passage-number strain ZIKV-#976-Uganda-1947 is a historical isolate 
from a monkey and it originates from the European Virus Archive goes global (EVAg, Ref: 007V-EVAg1585). 
ZIKV strains #976 was isolated in baby mouse brain in 1947 in Uganda and passaged 3 times, then in 1961 it was 
lyophilised and stored at −80 °C. Then, in 2017 the virus was rehydrated and inoculated on Vero E6 cells. It was 
propagated in Vero E6 cells 3 times before preparing virus stocks. All Zika virus strains were obtained as Vero E6 
cultures and further propagated once for this study resulting in passages p2, p7 or p4 giving TCID50 titers of the 
virus stocks 1.3 × 107 (first GWUH stock) or 1 × 108 (the second GWUH stock), 5.0 × 106 and 2.4 × 108, respec-
tively. A human influenza A virus strain A/Beijing/353/1989 (H3N2) was propagated in 11-days-old embryo-
nated chicken eggs at +36 °C for 3 days and the virus titer in human DCs was 2 × 109 21.
The differentiated DCs and macrophages and immortalized MEFs were infected with indicated ZIKV strains 
at different MOI values (based on TCID50 Vero E6 cell titers), as indicated in the figures. After 2 h of infection at 
+37 °C fresh media was added and the cells were incubated for different times depending on each experiment. 
Recombinant human IFN-β (Schering-Plough) was used at 10 or 100 IU/ml cencentrations to pretreat DCs or 
macrophages for 16 h before ZIKV infection. Infective Zika viruses were handled strictly under Biosafety Level 
(BSL) 3 laboratory conditions at the Finnish Institute for Health and Welfare (THL), Finland.
End-point dilution assay. For determining the viral titers from ZIKV samples Vero E6 cells were cultured 
in 96-well plates. A dilution series of up to 10−6 was made from each sample, and each dilution was used to infect 
8 parallel culture wells. The cytopathic effect was observed under the light microscope at day 7 post-infection, and 
each well was scored either positive or negative for virus infection. The Spearman-Karber method was used to 
calculate the results which are presented as log TCID50/ml and the detection limit for the assay was 0.499.
Antibodies against ZIKV NS3 or NS5 protein. Synthetic ZIKV NS3 or NS5 genes were ordered from 
GenArt (Thermo Fisher Scientific), based on ZIKV GWUH sequence. The coding sequence was cloned into a 
baculoviral expression vector GST-pBVboost53 to produce GST-NS3 or GST-NS5 expressing baculoviruses. For 
producing recombinant ZIKV proteins Sf9 cells were infected with GST-NS3 or GST-NS5 expressing baculo-
viruses for 42 h. Cells were collected, and ZIKV GST-NS3 or GST-NS5 were purified by glutathione Sepharose 
affinity chromatography and preparative SDS-PAGE as previously described53. The rabbit or guinea pig polyclonal 
antibodies against ZIKV NS3 or NS5 antigens were prepared by immunizing the animals with purified antigens 
(50 μg/immunization) for 4 times at 2 week intervals together with Freund’s incomplete (FCA) adjuvant (Difco 
laboratories). The animals were bled 10 days after the last immunization.
Immunofluorescence assay (IFA). For immunofluorescence microscopy cells were grown on glass cover-
slips for 24 h and infected with ZIKV as indicated in the figure legends. After infection, the cells were fixed with 
4% paraformaldehyde at RT for 30 min and permeabilized with 0.1% Triton X-100 for 5 min before staining with 
anti-ZIKV antisera. Polyclonal rabbit or guinea pig immune sera was used at a dilution of 1:200 for staining the 
coverslips at RT for 1 h. FITC-labeled goat anti-rabbit or goat anti-guinea pig antibodies (Invitrogen) were used in 
secondary staining. NucBlue Fixed Cell Ready Probes reagent (Life Technologies, DAPI) was added to secondary 
antibody staining solutions and slides were analyzed with fluorescence microscopy.
Flow Cytometry. For infectivity analyses ZIKV-infected DCs were collected from each blood donor sepa-
rately, cells were fixed with 4% paraformaldehyde at RT for 30 min and permeabilized with 0.1% Triton X-100 for 
5 min before staining with anti-ZIKV rabbit antisera and FITC-conjugated secondary antibodies (Invitrogen) at 
RT for 1 h. Flow cytometry was performed on FACSCanto II cytometer and analyzed using FACS Diva software 
(BD Biosciences).
RNA isolation and qRT-PCR. Virus-infected cells were harvested and total cellular RNA was isolated 
using the RNeasy Mini kit (Qiagen) including DNase digestion (RNase-free DNase kit, Qiagen). One µg of total 
cellular RNA was transcribed to cDNA using TaqMan Reverse Transcriptase kit (Applied Biosystems) with 
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random hexamers as primers. cDNAs were amplified by PCR using TaqMan Universal PCR Mastermix and Gene 
Expression Assays (Applied Biosystems). The ZIKV NS5 specific qRT-PCR primers used were modified from 
Faye et al.54 and were as previously described5. Cytokine or MxA mRNA levels were normalized against human 
18S rRNA or mouse Gapdh with TaqMan Endogenous Control kits (Applied Biosystems). Gene expression data 
is presented as a relative gene expression in relation to unstimulated samples in order to calculate the fold changes 
seen in infection experiments.
Immunoblotting. For protein analyses the cells from different blood donors were pooled to get sufficient 
amounts of proteins, and whole cell lysates were prepared in the passive lysis buffer of Dual Luciferase Assay Kit 
(Promega) containing 10 mM Na3PO4. Equal amounts of proteins (10–30 ug/lane) were separated on SDS-PAGE 
and transferred to Hybond-P polyvinylidene difluoride (PVDF) membranes (Amersham Biosciences). The 
membranes were blocked with 5% milk protein in PBS. Antibodies against IRF3 and MxA were as previously 
described21,22 and antibodies against ZIKV NS5 were prepared as described above. The staining was done in 
blocking buffer at RT for 1 h. Antibodies against phosphorylated IRF3 (P-IRF3, #4947), STAT2 (#72604), 
P-STAT2 (#88410) and GAPDH (#2118) were from Cell Signaling Technology, for β-Actin (SC-10731) from 
SantaCruz Biotechnology, and the stainings were done in Tris-buffered saline, pH 7.4 containing 5% BSA at +4 °C 
overnight. HRP-conjugated antibodies (Dako) were used in the secondary staining at RT for 1 h. Protein bands 
were visualized on HyperMax films using an ECL plus system (GE Healthcare).
Enzyme immunoassay (EIA). The secreted levels of IFN-λ1 or multiple subtypes of IFN-α were analysed 
from cell culture supernatant samples of different blood donors separately using LegendMaxTM Human IFN-λ1 
ELISA kit (BioLegend) or VeriKineTM Human IFN-α Multi subtype ELISA kit (PBL Assay Science), respectively.
Data availability
All the research material and the data produced in this study are available from the corresponding author upon 
request following the practices of our institute.
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